North Shore Family Dental Care Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1044 Northern Blvd Ste 106, Roslyn, NY 11576 Phone: 516-625-0088 Fax: 516-625-0008 |
Harbor Family Dental Llp Dentist Medicare: Not Enrolled in Medicare Practice Location: 55 Bryant Ave Ste 1, Roslyn, NY 11576 Phone: 718-344-0701 |
Flower Hill Dental Group Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1025 Northern Blvd, Roslyn, NY 11576 Phone: 516-365-7777 Fax: 516-869-8550 |
The North Shore Center For Comprehensive Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1025 Northern Blvd, Suite 101, Roslyn, NY 11576 Phone: 516-627-2234 Fax: 516-627-7031 |
Ira Goldberg, D.m.d., Pllc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1044 Northern Blvd, Suite 108, Roslyn, NY 11576 Phone: 516-484-1123 |
Dentistry Done Better Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1044 Northern Blvd #306, Roslyn, NY 11576 Phone: 576-466-1177 Fax: 516-466-0763 |
News Archive
A new preprint released on the medRxiv* server by researchers at the University of Innsbruck, Austria, takes this further in order to establish the limits of storage procedures while working on viral surveillance in this area.
A pattern of micro molecules can distinguish pancreatic cancer from normal and benign pancreatic tissue, new research suggests.
The U.S. Government has initiated a major effort to prevent and effectively treat Alzheimer's disease by 2025. However, a workgroup of nearly 40 Alzheimer's researchers and scientists says the research milestones in the U.S. Government's National Plan to Address Alzheimer's Disease must be broadened in scope, increased in scale, and adequately funded in order to successfully achieve this goal.
Researchers in the Netherlands suggest that mental exercises could be just as effective as physically working the muscles when it comes to easing back pain.
STENTYS S.A., a medical technology company that is commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today that it has enrolled the 500-patient target of the international APPOSITION III study for its Self-Apposing Stent.
› Verified 5 days ago